Trial Profile

Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 28 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

14 Nov 2022 Results assessing the use of Tc99m Tilmanocept imaging in predicting clinical response in rheumatoid arthritis patients assessing the presented at the ACR Convergence 2022.
14 Nov 2022 According to a Navidea Biopharmaceuticals media release, the data from this study presented at the American College of Rheumatology
15 Sep 2022 According to a Navidea Biopharmaceuticals media release, the data from this study will be presented at the American College of Rheumatology Annual Meeting, 2022.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com